HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.
HIV Prevention in SA Needs Local Lenacapavir Manufacturing
Original Article by Stavros Nicolaou | Sunday Times | 14 December 2025
HIV prevention in South Africa hinges on local drug manufacturing to ensure access, reduce delays, and enable regional health security.
More Posts
Mpox Cases in SA Rise as Local Transmission Accelerates
Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.
Read more...
NHLS Scrambles as Pathology Services Funding Runs Dry
The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt
Read more...
Momentum Group Posts Record Earnings
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.
Read more...